Menu
Back to User profile » Ms Victoria Higgins
Papers published by Ms Victoria Higgins:
Improving Assessment of Adherence Behaviors and Drivers: Targeted Literature Review and Concept Elicitation Interviews in Multiple Countries and Disease Populations
Bentley S, Exall E, Morgan L, Roche N, Khunti K, Rossom R, Piercy J, Arbuckle R, Higgins VS
Patient Preference and Adherence 2024, 18:1231-1242
Published Date: 17 June 2024
Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice
Yiu G, Gulati S, Higgins V, Coak E, Mascia D, Kim E, Spicer G, Tabano D
Clinical Ophthalmology 2024, 18:1679-1690
Published Date: 6 June 2024
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey
Anstee QM, Hallsworth K, Lynch N, Hauvespre A, Mansour E, Kozma S, Bottomley J, Milligan G, Piercy J, Higgins V
Pragmatic and Observational Research 2023, 14:13-27
Published Date: 24 February 2023
Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries
Bentley S, Morgan L, Exall E, Arbuckle R, Rossom RC, Roche N, Khunti K, Higgins V, Piercy J
Patient Preference and Adherence 2022, 16:2579-2592
Published Date: 15 September 2022
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V
Diabetes, Metabolic Syndrome and Obesity 2017, 10:403-412
Published Date: 29 September 2017
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M
Diabetes, Metabolic Syndrome and Obesity 2016, 9:371-380
Published Date: 1 November 2016
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification
Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:551-561
Published Date: 28 May 2014
Impact of night-time symptoms in COPD: a real-world study in five European countries
Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:595-603
Published Date: 27 November 2013